Exploration and Evaluation of Amygdalo-Hippocampectomy According to Prof. Coubes' Technique: An Anatomical, Clinical, and Educational Approach

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorUniversity Hospital, Montpellier

About this trial

The goal of this retrospective study is to evaluate the long-term clinical outcomes and complications associated with amygdalo-hippocampectomy using the surgical technique developed by Pr. Coubes (Montpellier, FRANCE). The main questions it aims to answer are:

* What are the complications and evolution of clinical outcomes in patients treated with this technique for hippocampal sclerosis or other intern temporal diseases ? * What variables are associated with better seizure control following surgery?

Participants include 234 patients treated over the last 30 years at the CHU de Montpellier, FRANCE. The study will analyze clinical data, including seizure outcomes based on ILAE criteria, post-operative complications, and factors influencing recovery and reintegration into daily life.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who had undergone an Amygdalo-Hippocampectomy according to the surgical procedure that we describe

Disqualifiers

Patients who did not have this exact procedure.

Trial population

All the patients that have been followed in the University Hospital of Montpellier, France in the Epileptic Ward.

Trial design

Design model

Cohort

Time perspective

Retrospective

Treatments tested in this trial

  • Amygdalo-Hippocampectomy

    Procedure/Surgery

    This technique is characterized by specific hallmarks that distinguish it from other approaches, including the Yasargil technique and newer minimally invasive methods. It integrates precise anatomical targeting with optimized surgical pathways to enhance outcomes in patients with those pathologies. The approach of the choroidal fissure will be explained in the article. By addressing limitations observed in traditional techniques, it aims to minimize neurological deficits while achieving better seizure control.

Treatment groups

3,504 Participants
are divided into 1 treatment group
Group A: Patients operated1 intervention

Trial outcomes

Primary outcomes

1

Post-Surgical Classification assessing epilepsy's control

The ILAE post-surgical classification system is used to categorize seizure outcomes after epilepsy surgery. It provides a standardized way to evaluate how effectively surgery controls seizures, enabling consistency in reporting and comparison of surgical outcomes across studies and clinical settings. In those cases of drug-resistance epilepsy, we will assess the epilepsy's control after the surgery. 1. Completely seizure free; no auras 2. Only auras; no other seizures 3. One to three seizure days per year 4. Four to 12 seizure days per year 5. Daily seizures 6. More than 100% increase of baseline ; auras

Time frame
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to twenty years. The study starts in 2024 and ends in 2025, which lasts one year.

Secondary outcomes

1

Post-operative complications : Infections

Each post-operative complications have been studied during the medical follow-up. It included the immediate post-operative complications such as presence of an infection.

Time frame
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to twenty years. The study starts in 2024 and ends in 2025, which lasts one year
2

Post-operative complications : Hematomas

Each post-operative complications have been studied during the medical follow-up. It included the immediate post-operative complications such as presence of hematoma.

Time frame
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to twenty years. The study starts in 2024 and ends in 2025, which lasts one year.
3

Post-operative way of life

As part of this research on the surgery, the investigators are studying the post-surgical way of life of patients who have undergone this procedure. This includes evaluating various aspects of their daily functioning, such as autonomy, cognitive and psychiatric outcomes, social integration, and overall quality of life. By analyzing these factors, the investigators aim to better understand the long-term impact of hippocampectomy and identify potential areas for improving patient care and rehabilitation strategies.

Time frame
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to twenty years. The study starts in 2024 and ends in 2025, which lasts one year.
4

Risk factors or predisposing factors of success or failure after Amygdalo-Hippocampectomy

Among the patients who underwent favourable and unfavourable evolutions, we will assess the risk factors and the predisposing factors such as febrile seizure, medical history, etiologic lesions.

Time frame
From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to twenty years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.